Syneos Health [SYENS] vs Azelis Group NV [AZE] Detailed Stock Comparison

Syneos Health

Euronext
Loading...

Azelis Group NV

Euronext
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Syneos Health wins in 8 metrics, Azelis Group NV wins in 9 metrics, with 0 ties. Azelis Group NV appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricSyneos HealthAzelis Group NVBetter
P/E Ratio (TTM)377.8617.72Azelis Group NV
Price-to-Book Ratio1.191.12Azelis Group NV
Debt-to-Equity Ratio45.5777.22Syneos Health
PEG Ratio5.0410.63Syneos Health
EV/EBITDA7.7010.34Syneos Health
Profit Margin (TTM)-1.30%4.01%Azelis Group NV
Operating Margin (TTM)10.86%8.89%Syneos Health
EBITDA Margin (TTM)10.86%8.89%Syneos Health
Return on Equity-1.20%6.41%Azelis Group NV
Return on Assets (TTM)3.16%3.98%Azelis Group NV
Free Cash Flow (TTM)$217.00M$309.06MAzelis Group NV
Dividend YieldN/A3.25%N/A
1-Year Return-14.86%-40.78%Syneos Health
Price-to-Sales Ratio (TTM)1.100.70Azelis Group NV
Enterprise Value$9.15B$4.61BSyneos Health
EV/Revenue Ratio1.371.09Azelis Group NV
Gross Profit Margin (TTM)30.87%N/AN/A
Revenue per Share (TTM)$64$17Syneos Health
Earnings per Share (Diluted)$-0.81$0.69Azelis Group NV
Beta (Stock Volatility)N/A0.54N/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Syneos Health vs Azelis Group NV Stock Performance Analysis

Loading Price Chart...

Syneos Health
Azelis Group NV
Syneos Health Stock Overview | Azelis Group NV Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Syneos Health0.09%-5.49%-12.32%1.44%1.92%-3.49%
Azelis Group NV-1.50%-2.96%-12.90%-10.86%-34.04%-38.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Syneos Health-14.86%-28.28%-28.28%-28.28%-28.28%-28.28%
Azelis Group NV-40.78%-48.16%-57.79%-57.79%-57.79%-57.79%

News Based Sentiment: Syneos Health vs Azelis Group NV

Syneos Health

News based Sentiment: NEUTRAL

September was a pivotal month marked by a major corporate event – the acquisition of Syneos Health and the subsequent emergence of Syensqo SA/NV. While the acquisition impacts former Syneos Health investors, Syensqo is actively building its profile through share buybacks, product innovation, and a positive analyst outlook, creating a neutral overall investment story.

View Syneos Health News Sentiment Analysis

Azelis Group NV

News based Sentiment: MIXED

September presented a mixed bag for Azelis, with a strategic acquisition overshadowed by a notable analyst downgrade and subsequent stock volatility. While positive insider activity and a 'Buy' rating from ING offer some optimism, the conflicting signals create uncertainty for investors, making it a significant but complex month for the company.

View Azelis Group NV News Sentiment Analysis

Performance & Financial Health Analysis: Syneos Health vs Azelis Group NV

MetricSYENSAZE
Market Information
Market Cap i€7.38B€2.93B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i136,607543,590
90 Day Avg. Volume i126,951405,727
Last Close€67.78€11.82
52 Week Range€53.70 - €84.85€11.71 - €21.00
% from 52W High-20.12%-43.71%
All-Time High€109.90 (Dec 11, 2023)€29.90 (Sep 13, 2021)
% from All-Time High-38.33%-60.47%
Growth Metrics
Quarterly Revenue Growth-0.08%0.01%
Quarterly Earnings Growth0.72%-0.12%
Financial Health
Profit Margin (TTM) i-0.01%0.04%
Operating Margin (TTM) i0.11%0.09%
Return on Equity (TTM) i-0.01%0.06%
Debt to Equity (MRQ) i45.5777.22
Cash & Liquidity
Book Value per Share (MRQ)€60.47€10.90
Cash per Share (MRQ)€12.85€1.86
Operating Cash Flow (TTM) i€749.00M€323.63M
Levered Free Cash Flow (TTM) i€451.50M€33.84M
Dividends
Last 12-Month Dividend Yield iN/A3.25%
Last 12-Month Dividend iN/A€0.45

Valuation & Enterprise Metrics Analysis: Syneos Health vs Azelis Group NV

MetricSYENSAZE
Price Ratios
P/E Ratio (TTM) i377.8617.72
Forward P/E i9.6510.63
PEG Ratio i5.0410.63
Price to Sales (TTM) i1.100.70
Price to Book (MRQ) i1.191.12
Market Capitalization
Market Capitalization i€7.38B€2.93B
Enterprise Value i€9.15B€4.61B
Enterprise Value Metrics
Enterprise to Revenue i1.371.09
Enterprise to EBITDA i7.7010.34
Risk & Other Metrics
Beta iN/A0.54
Book Value per Share (MRQ) i€60.47€10.90

Financial Statements Comparison: Syneos Health vs Azelis Group NV

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SYENSAZE
Revenue/Sales i€1.68BN/A
Cost of Goods Sold i€1.16BN/A
Gross Profit i€514.00MN/A
Research & Development i€78.00MN/A
Operating Income (EBIT) i€147.00MN/A
EBITDA i€306.00MN/A
Pre-Tax Income i€29.00MN/A
Income Tax i€27.00MN/A
Net Income (Profit) i€2.00MN/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SYENSAZE
Cash & Equivalents i€579.00M€303.95M
Total Current Assets i€3.28B€1.58B
Total Current Liabilities i€2.07B€818.87M
Long-Term Debt i€1.77B€1.75B
Total Shareholders Equity i€7.27B€2.92B
Retained Earnings i€4.77B€876.33M
Property, Plant & Equipment i€3.85B€103.92M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SYENSAZE
Operating Cash Flow i€40.00MN/A
Capital Expenditures i€-143.00MN/A
Free Cash Flow i€9.00MN/A
Debt Repayment i€-166.00MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSYENSAZE
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i136,607543,590
Average Daily Volume (90 Day) i126,951405,727
Shares Outstanding i103.45M243.51M
Float Shares i69.83M173.84M
% Held by Insiders i0.31%0.00%
% Held by Institutions i0.28%0.80%

Dividend Analysis & Yield Comparison: Syneos Health vs Azelis Group NV

MetricSYENSAZE
Last 12-Month Dividend iN/A€0.45
Last 12-Month Dividend Yield iN/A3.25%
3-Year Avg Annual Dividend iN/A€0.24
3-Year Avg Dividend Yield iN/A1.44%
3-Year Total Dividends iN/A€0.73
Ex-Dividend DateN/AJun 27, 2025